Clinical Trial: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07540910) titled 'A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults' on April 13.

Brief Summary: This study is a randomized, double-blind, sponsor-open, placebo-controlled study. It will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered single and multiple doses of EDP-978 in healthy adult subjects.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Chronic Inducible Urticaria Chronic Spontaneous Urticaria

Intervention: DRUG: EDP-978

Oral administration

DRUG: Placebo

Placebo to match EDP-9...